Key Quantitative Figures

  • Share price significantly increased to ₹100.63 on November 20, 2026
  • Scrip number: 531308
  • The price movement represents a substantial rise in equity share price

Dates of Action

  • Letter dated: Friday, November 20, 2026
  • Recent trading period showing frequent abnormal price movements

Parties Involved

  • Complainant: CENTENIAL SURGICAL SUTURE LTD represented by Mahima BATHWAL, Company Secretary & Compliance Officer (Membership No. ACS A35069)
  • Regulatory Authorities Addressed:
  • BSE Limited, Investigation/Surveillance Department
  • Securities & Exchange Board of India (SEBI), Investigation/Surveillance Department
  • Suspected Parties: Potential fraudulent persons from neighboring countries (Pakistan/Nepal/Bangladesh) employed in companies and living in India
  • Trading Entities: Multiple brokers and their clients spread across India, including repeated buyers

Observed Trading Patterns

  • Abnormal price increase not supported by any corporate announcements or material changes in business activities
  • Frequent unusual trades in company shares
  • Suspected manipulative trade patterns observed
  • Buyers through brokers spread all over India with some repeated buyers
  • Common persons/entities involved in trading during the period of price rise
  • Transactions appear unnatural and highly suspicious
  • Evidence of synchronized trading among buyers/operators
  • Possible use of upper/lower circuit mechanisms of BSE Limited
  • Suspected circular trading activities across India

Company's Position and Requests

  • Company confirms no material announcements were made that could justify significant price increase/decrease
  • Promoters, directors, and associates have no role in the suspected misuse, unethical or illegal activities
  • Requests urgent attention for possible misuse/unethical/unusual trades
  • Seeks complete investigation into the scrip for probable violation of securities laws
  • Urges investigation of price movement and operations in recent past
  • Requests appropriate penal actions against concerned broking house(s) and/or their clients
  • Company ready to provide any assistance required for detailed investigation
  • Requests treatment as emergency case

Financial Impact

Financial impact not quantified in the disclosure. The company emphasizes protection of shareholder interests and prevention of adverse effects on company reputation.

Geographic Operations

  • Manufacturing Facility: B-17/F-29/F-22/23 MIDC, Murbad, Thane 421401, Maharashtra
  • Sales Office - Mumbai: 1st Floor, Palat Complex CHS Ltd, Bhandarkar Road, Matunga (East), Mumbai 400019, Maharashtra
  • Sales Office - Kolkata: Flat No. N-1, Ground Floor, 385 Purbachal, Kalitala Road, P.S. Kasba, Kolkata 700078, West Bengal